| 000 | 01755 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517002746.0 | ||
| 264 | 0 | _c20150709 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1936-2625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFan, Tian-Yu | |
| 245 | 0 | 0 |
_aInhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma. _h[electronic resource] |
| 260 |
_bInternational journal of clinical and experimental pathology _c2014 |
||
| 300 |
_a6662-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xgenetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEnhancer of Zeste Homolog 2 Protein |
| 650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aGlioblastoma _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aPolycomb Repressive Complex 2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aWang, Hai | |
| 700 | 1 | _aXiang, Peng | |
| 700 | 1 | _aLiu, Ya-Wei | |
| 700 | 1 | _aLi, He-Zhen | |
| 700 | 1 | _aLei, Bing-Xi | |
| 700 | 1 | _aYu, Meng | |
| 700 | 1 | _aQi, Song-Tao | |
| 773 | 0 |
_tInternational journal of clinical and experimental pathology _gvol. 7 _gno. 10 _gp. 6662-70 |
|
| 999 |
_c24357368 _d24357368 |
||